Lisa M. DeFrancesco - 28 Feb 2026 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Signature
/s/ Lisa M. DeFrancesco
Issuer symbol
LXRX
Transactions as of
28 Feb 2026
Net transactions value
-$109,621
Form type
4
Filing time
03 Mar 2026, 07:18:00 UTC
Previous filing
17 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DeFrancesco Lisa SVP, IR and Corp Comm 2445 TECHNOLOGY FOREST BLVD, 11TH FLOOR, SPRING /s/ Lisa M. DeFrancesco 03 Mar 2026 0001846325

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +24,674 +158% 40,251 28 Feb 2026 Direct F1
transaction LXRX Common Stock Options Exercise +128,190 +318% 168,441 28 Feb 2026 Direct F1
transaction LXRX Common Stock Tax liability $109,621 -74,572 -44% $1.47 93,869 28 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -24,674 -50% 24,673 28 Feb 2026 Common Stock 24,674 Direct F1, F3, F4
transaction LXRX Restricted Stock Units Options Exercise -128,190 -33% 256,380 28 Feb 2026 Common Stock 128,190 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.